| Authors: |
Bertoldo F; Department of Medicine, Universita' di Verona, Verona, Italy., Silvestris F; Department of Biomedical Sciences and Human Oncology, Section of Clinical Oncology, University of Bari 'A. Moro', Bari, Italy., Ibrahim T; Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Cognetti F; Division Oncology, Regina Elena Institute, Rome, Italy., Generali D; UO Multidisciplinare di Patologia Mammaria, US Terapia Molecolare e Farmacogenomica, AZ. Istituti Ospitalieri di Cremona, Cremona, Italy., Ripamonti CI; Supportive Care in Cancer Unit, Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Amadori D; Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Colleoni MA; Division of Medical Senology, European Institute of Oncology, Milan, Italy., Conte P; Oncologia Medica 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Del Mastro L; UO Sviluppo Terapie Innovative, IRCCS AOU San Martino, IST, National Institute for Cancer Research, Genoa, Italy., De Placido S; Department of Endocrinology and Molecular and Clinical Oncology, University of Naples Federico II, Naples, Italy., Ortega C; Oncology Unit, IRCC Candiolo, Torino, Italy., Santini D; Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy. Electronic address: d.santini@unicampus.it. |
